Gr-Vax

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGr-Vax

Drug Alias NameGR-Vax (ERYtech Pharma)

ClassificationCell and gene therapy > Cell therapyBiologics > Antigen > Tumor antigenVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPhaxiam Therapeutics SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPhaxiam Therapeutics SA

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A